Simponi IV (golimumab)

pCPA File Number: 20932

Negotiation Status:

Concluded without agreement

Indication(s):

Rheumatoid Arthritis

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

SR0351-000

pCPA Engagement Letter Issued:

2014-10-06

Negotiation Process Concluded:

2016-04-19